CMR FigSearch
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jenssen, H.
Right arrow Articles by Hancock, R. E. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jenssen, H.
Right arrow Articles by Hancock, R. E. W.

 Previous Article  |  Next Article 

Clinical Microbiology Reviews, July 2006, p. 491-511, Vol. 19, No. 3
0893-8512/06/$08.00+0     doi:10.1128/CMR.00056-05
Copyright © 2006, American Society for Microbiology. All Rights Reserved.

Peptide Antimicrobial Agents

Håvard Jenssen, Pamela Hamill, and Robert E. W. Hancock*

Centre for Microbial Diseases and Immunity Research, University of British Columbia, Lower Mall Research Station, 232-2259 Lower Mall, Vancouver, British Columbia V6T 1Z4, Canada

Antimicrobial host defense peptides are produced by all complex organisms as well as some microbes and have diverse and complex antimicrobial activities. Collectively these peptides demonstrate a broad range of antiviral and antibacterial activities and modes of action, and it is important to distinguish between direct microbicidal and indirect activities against such pathogens. The structural requirements of peptides for antiviral and antibacterial activities are evaluated in light of the diverse set of primary and secondary structures described for host defense peptides. Peptides with antifungal and antiparasitic activities are discussed in less detail, although the broad-spectrum activities of such peptides indicate that they are important host defense molecules. Knowledge regarding the relationship between peptide structure and function as well as their mechanism of action is being applied in the design of antimicrobial peptide variants as potential novel therapeutic agents.


* Corresponding author. Mailing address: Centre for Microbial Diseases and Immunity Research, University of British Columbia, Lower Mall Research Station, 232-2259 Lower Mall, Vancouver, British Columbia V6T 1Z4, Canada. Phone: (604) 822-2682. Fax: (604) 827-5566. E-mail: bob{at}cmdr.ubc.ca.


Clinical Microbiology Reviews, July 2006, p. 491-511, Vol. 19, No. 3
0893-8512/06/$08.00+0     doi:10.1128/CMR.00056-05
Copyright © 2006, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Antimicrob. Agents Chemother. Clin. Vaccine Immunol.
J. Clin. Microbiol. ALL ASM JOURNALS

Copyright © 2006 by the American Society for Microbiology. All rights reserved.